Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors.

Autor: Shatara M; Division of Hematology and Oncology, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri, USA., Blue M; Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital and Ohio State University College of Medicine, Columbus, Ohio, USA., Stanek J; Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital and Ohio State University College of Medicine, Columbus, Ohio, USA., Liu YA; Departments of Ophthalmology, Neurology, and Neurosurgery, University of California, Davis, Sacramento, California, USA., Prevedello DM; Department of Neurological Surgery, Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Giglio P; Division of Neuro-Oncology, Ohio State University Wexner Medical Center, James Cancer Center, Columbus, Ohio, USA., Puduvalli VK; Department of Neuro-oncology, MD Anderson Cancer Center, Houston, Texas, USA., Gardner SL; Department of Pediatrics, New York University Grossman School of Medicine, New York, New York, USA., Allen JC; Department of Pediatrics, New York University Grossman School of Medicine, New York, New York, USA., Wong KK; Division of Hematology and Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles and Keck School of Medicine of University of Southern California, Los Angeles, California, USA.; Department of Radiation Oncology, University of Southern California, Los Angeles, California, USA., Nelson MD; Department of Radiology, Children's Hospital of Los Angeles, Los Angeles, California, USA., Gilles FH; Department of Pathology, Children's Hospital of Los Angeles, Los Angeles, California, USA., Adams RH; Phoenix Children's Center for Cancer & Blood Disorders, University of Arizona School of Medicine-Phoenix, and Mayo Clinic, Arizona, USA., Pauly J; Division of Hematology and Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, California, USA., O'Halloran K; Division of Hematology and Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles and Keck School of Medicine of University of Southern California, Los Angeles, California, USA., Margol AS; Division of Hematology and Oncology, Cancer and Blood Disease Institute, Children's Hospital Los Angeles and Keck School of Medicine of University of Southern California, Los Angeles, California, USA., Dhall G; Division of Pediatric Hematology/Oncology, Children's Hospital of Alabama and the University of Alabama at Birmingham, Birmingham, Alabama, USA., Finlay JL; Division of Hematology, Oncology, Blood and Marrow Transplant, Nationwide Children's Hospital and Ohio State University College of Medicine, Columbus, Ohio, USA.

Publikováno v: Neuro-oncology practice [Neurooncol Pract] 2023 Oct 14; Vol. 11 (2), pp. 188-198. Date of Electronic Publication: 2023 Oct 14 (Print Publication: 2024).